European Digital HealthTech Conference 2024

Agenda

Programme  14 May


May 14, 2024
12:45 PM1:15 PM

Arrival and registration

May 14, 2024
1:15 PM1:30 PM

Welcome address

JA
Jean-Philippe Arie
LuxinnovationHealth Tech Cluster Manager
CB
Carole Brückler
Luxembourg Ministry of the EconomyHead of Digital Health Technologies
May 14, 2024
1:30 PM1:40 PM

Opening speech

LD
Lex Delles
Minister of the Economy, SME, Energy and TourismLuxembourg
May 14, 2024
1:40 PM2:00 PM

Opening remarks

MK
Menno Kok
European Institute of Innovation and Technology (EIT) HealthManaging Director EIT Health Belgium-Netherlands


Data collection and access: national and European challenges

Fair and easy access to patient data for all stakeholders is an integral component of digital health innovation. This segment addresses challenges inherent to the generation, storage, access, re-use, and quality of patient data. It specifically considers: 

 Â· European and national level initiatives
 Â· Cross-country projects in digital health 
 Â· Engagement of healthcare providers and patients 
 Â· Primary and secondary use of patient data
 Â· Interoperability in healthcare

May 14, 2024
2:00 PM2:15 PM

The European Health Data Space

MM
Marco Marsella
European CommissionDirector for Digital, EU4Health and Health Systems Modernisation, DG SANTE
May 14, 2024
2:15 PM2:25 PM

Digitalisation and access to health data – Initiatives at national level

IZ
Isabelle Zablit
Europe & International director for digital healthFrench Health Ministry
May 14, 2024
2:25 PM2:35 PM

Transnational collaboration to generate federated, interoperable and normalised patient data: Lessons from the CLINNOVA project

MF
Maximilian Fünfgeld
Luxembourg Institute of HealthChief Medical Information Officer


From patient data to business opportunities

Building an algorithm using patient data is not sufficient to build a successful digital health company. A solid reflexion around the business model is needed.

 Â· What are the different business models in digital health? 
 Â· What are the European market’s specificities and challenges? 
 Â· Who pays for the services? 
 Â· Medical device or non-certified technologies? The question of certification in the business model reflexion.
May 14, 2024
2:35 PM2:45 PM

Business opportunities in digital health: Views from the European market

JW
Jerome Wittamer
Expon CapitalManaging Partner
May 14, 2024
2:45 PM2:55 PM

Creating start-up ecosystems around medical equipment investments

ZT
Zied Tayeb
Myelin-HFounder & CEO
May 14, 2024
2:55 PM3:40 PM

Round table I Business models: Navigating challenges of use cases and managing data access

AJ
Antoine Jomier
Incepto MedicalCEO & Co Founder
MM
Marc Molitor
DoctenaCo-Founder
SS-M
Stéphanie Silvestri - MODERATOR
LuxinnovationTransformation Project Manager
ZT
Zied Tayeb
Myelin-HFounder & CEO
AV
Alina Vorontsova
PsyTech VR LuxembourgEuropean Market Leader

May 14, 2024
3:40 PM4:10 PM

Coffee Break


Market access: The journey towards certification and reimbursement

Market access for digital health technologies includes the challenging step of certification. Certification is mandatory for market access, but not enough to access social security reimbursement.

· A look at the different processes to access reimbursement for each country
· The need for harmonisation
May 14, 2024
4:10 PM4:20 PM

Clinical Evidence for CE marking and proof of value in Europe

JK
Jochen Klucken
Uni Luxembourg, LIH, CHLChair of Digital Medicine
May 14, 2024
4:20 PM4:30 PM

The reimbursement of mobile medical applications in Belgium: why we adapted the mHealth pyramid?

UC
Ulla Cahay
National Institute for Health and Disability Insurance (NIHDI)Policy officer
May 14, 2024
4:30 PM4:40 PM

Harmonisation of evaluation standards for digital medical devices in Europe

MM
Marco Marchetti
AgenasDirector HTA Department, National Agency for Regional Health Care (Agenas), Italy & Co-Chair, HTA Member State Coordination Group (HTACG), EU
May 14, 2024
4:40 PM5:15 PM

Round table I Certification and market access: Good practices for reimbursement

SB
Stefan Bartosch
DMACCEO
MB-M
Magali Boers - MODERATOR
Ministry of Health and Social Security LuxembourgDigital Health
UC
Ulla Cahay
National Institute for Health and Disability Insurance (NIHDI)Policy officer
MJ
Mihael Jakovac
Kranus HealthHead of Market Access
MM
Marco Marchetti
AgenasDirector HTA Department, National Agency for Regional Health Care (Agenas), Italy & Co-Chair, HTA Member State Coordination Group (HTACG), EU

Closing & Networking

May 14, 2024
5:15 PM5:20 PM

Closing remarks

JA
Jean-Philippe Arie
LuxinnovationHealth Tech Cluster Manager
May 14, 2024
5:20 PM7:00 PM

B2B session

May 14, 2024
5:20 PM8:00 PM

Networking cocktail

Day 2

Programme  15 May


May 15, 2024
8:00 AM8:45 AM

B2B session

May 15, 2024
8:00 AM8:45 AM

Registration and breakfast

May 15, 2024
8:45 AM9:05 AM

Welcome and opening remarks

JA
Jean-Philippe Arie
LuxinnovationHealth Tech Cluster Manager


Good practices for the clinical validation of digital technologies

The clinical validation of digital health technologies is a challenging step due to the complexity of the selection of the endpoints and the search for the right partners. This segment of the conference explores the following areas:

 Â· Engagement of patients in clinical trials 
 Â· Specificities of digital technologies in clinical trials 
 Â· Readiness of society and patients for digital technologies and preventive solutions
May 15, 2024
9:05 AM9:15 AM

Promoting trustworthy AI in healthcare in Europe – European Commission initiatives

HW
Hannah-Marie Weller
Unit H3, DG CONNECT, European CommissionPolicy Officer
May 15, 2024
9:15 AM9:30 AM

Modelling and Methodological challenges for clinical evaluation of Digital Medical Devices based on AI

SZ
Sarah Zohar
InsermDirector of Research
May 15, 2024
9:30 AM9:45 AM

How patient voices can shape the future of healthcare/Advocating for enhanced patient involvement in healthcare/ Driving change through active engagement

MT
Milana Trucl
European Patients’ ForumPolicy Officer
May 15, 2024
9:45 AM10:30 AM

Round table I Clinical validation: Promoting the adoption of digital technologies by patients and society

RC
Romit Choudhury
Softbrik AICo-Founder & CTO
DT-M
Daniel Theisen - MODERATOR
ALAN a.s.b.l. Maladies Rares LuxembourgDirector
MT
Milana Trucl
European Patients’ ForumPolicy Officer
PVR
Patricia Van Rompuy
Koios CareQuality and Clinical Trial Lead
SZ
Sarah Zohar
InsermDirector of Research

May 14, 2024
10:30 AM11:00 AM

Coffee Break


Funding pathways from research to commercialisation

  • From research to scale-up and commercialisation, investors are essential for the successful launch of a digital health solution. 
  • Each development opens up different funding opportunities.
May 15, 2024
11:00 AM11:15 AM

Article 51 of the French Social Security Financing Act

NL
Natacha Lemaire
French Ministry of HealthRapporteur General
May 15, 2024
11:15 AM12:05 PM

Round table I Funding opportunities for digital health technologies: What funding instruments for each stage of development?

CB-M
Carole Brückler - MODERATOR
Luxembourg Ministry of EconomyHead of Digital Health Technologies
GD
Guilhem Davezac
SNCIEconomic Attaché
HE
Hayley Every
EIT Health Belgium-NetherlandsEntrepreneurship Lead
NL
Natacha Lemaire
French Ministry of HealthRapporteur General
BM
Bert-Arjan Millenaar
NLC Health VenturesFounder & CEO
FR
Fabienne Roussel
Vesalius Biocapital IV PartnersPartner
May 15, 2024
12:05 PM12:20 PM

Interactive wrap-up with audience

JA
Jean-Philippe Arie
LuxinnovationHealth Tech Cluster Manager
MW
Marco Wendel
Medical Valley EMN e.VManaging Director

Closing  & Networking


May 15, 2024
12:20 PM12:30 PM

Closing address

MD
Martine Deprez
Minister of Health and Social SecurityLuxembourg
May 15, 2024
12:30 PM1:30 PM

B2B session

May 15, 2024
12:30 PM3:00 PM

Standing lunch